- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Ex-BC Premier Joins Constellation Brands Board, Praises Canopy
Former politician Christy Clark praised Canopy Growth and Constellation Brands for their safe creation and distribution of cannabis products.
Former British Columbia Premier Christy Clark said Canopy Growth (NYSE:CGC,TSX:WEED) is the “best positioned of all the companies” in the highly regulated cannabis sector.
Constellation Brands (NYSE:STZ), one of Canopy Growth’s biggest partners, confirmed Clark’s appointment to its board of directors in September, alongside Jose Manuel Madero, citing Clark’s “extensive knowledge” of Canada’s regulatory and political environment as benefits.
Clark sat as the provincial premier from 2011 to 2017 after working as both the minister of education and minister of children and family development in British Columbia.
In an interview with BNN Bloomberg on Friday (October 4), the former politician spoke about her excitement at joining the ranks at Constellation, a company she said is skilled at delivering on products in highly regulated industries.
Clark noted that the fledgling regulatory environment of the marijuana market won’t be well served by having a lot of smaller companies selling cannabis, but said Canopy Growth and Constellation have the capability to make the safe creation and distribution of cannabis products possible.
“There aren’t really any other companies in the cannabis space at the moment that have this level of capacity,” she said.
The former British Columbia premier isn’t the only player in the cannabis space with a political past. Former Canadian Prime Minister Brian Mulroney and former Speaker of the House John Boehner have both backed cannabis company Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF), another firm with a Canopy Growth deal.
Clark added that there is “huge potential on the (intellectual property) side” when it comes to the nascent industry, and said that further research on the medicinal applications of marijuana will be the biggest driver of growth. It is a space, she said, that Constellation will dominate.
The American beer maker pumped C$5 billion into Canopy last year to assist in branding, intellectual property and retailing for the cannabis company.
Clark’s addition to Constellation’s roster was another big management move for the company after former Canopy CEO Bruce Linton was pushed out of his role as chief executive.
With the investment, a conditional board reconfigurement was set, and that same board, largely composed of Constellation executives, terminated Linton after being unimpressed by some less-than-stellar quarterly results.
Shares of Constellation took a hit last week after it released its results for Q2 2020 on Thursday (October 3). The company reported a loss of US$484.4 million from its stake in Canopy Growth.
Constellation also reported a US$757 million unrealized net gain in reported basis results since its initial C$245 million investment into Canopy in 2017. A US$839 million decrease in the fair value of its investment into Canopy was also recognized during the latest quarter for the alcohol maker.
Shares of Constellation dropped after the earnings report was released last week, falling 8.2 percent from a high of US$208.14 on Wednesday (October 2) to a low of US$191.02 on Thursday.
Constellation closed the trading day on Monday (October 7) at US$188.74.
Canopy Growth shares fared a bit better last week with a bit of fluctuation in New York from a high on Wednesday of US$22.58 to a low of US$21.52 on Thursday, a 4.7 percent decrease in value. Canopy was at US$22.23 at market close on Monday.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.